TY - JOUR AU - Gilmore, A. B. AU - Fooks, G. AU - Drope, J. AU - Bialous, S. A. AU - Jackson, R. R. PY - 2015 DA - 2015// TI - Exposing and addressing tobacco industry conduct in low-income and middle-income countries JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(15)60312-9 DO - 10.1016/S0140-6736(15)60312-9 ID - Gilmore2015 ER - TY - BOOK PY - 2009 DA - 2009// TI - Tobacco Industry Interference with Tobacco Control PB - WHO CY - Geneva ID - ref2 ER - TY - JOUR AU - Bernstein, A. M. AU - Koning, L. AU - Flint, A. J. AU - Rexrode, K. M. AU - Willett, W. C. PY - 2012 DA - 2012// TI - Soda consumption and the risk of stroke in men and women JO - Am J Clin Nutr VL - 95 UR - https://doi.org/10.3945/ajcn.111.030205 DO - 10.3945/ajcn.111.030205 ID - Bernstein2012 ER - TY - JOUR AU - Hu, Y. AU - Costenbader, K. H. AU - Gao, X. PY - 2014 DA - 2014// TI - Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women JO - Am J Clin Nutr VL - 100 UR - https://doi.org/10.3945/ajcn.114.086918 DO - 10.3945/ajcn.114.086918 ID - Hu2014 ER - TY - JOUR AU - Siervo, M. AU - Montagnese, C. AU - Mathers, J. C. AU - Soroka, K. R. AU - Stephan, B. C. AU - Wells, J. C. PY - 2014 DA - 2014// TI - Sugar consumption and global prevalence of obesity and hypertension: an ecological analysis JO - Public Health Nutr VL - 17 UR - https://doi.org/10.1017/S1368980013000141 DO - 10.1017/S1368980013000141 ID - Siervo2014 ER - TY - BOOK PY - 2015 DA - 2015// TI - Scientific Report of the 2015 Dietary Guidelines Advisory Committee PB - USDA and US Department of Health and Human Services CY - Washington, DC ID - ref6 ER - TY - JOUR AU - Millar, J. S. PY - 2013 DA - 2013// TI - The corporate determinants of health: how big business affects our health, and the need for government action JO - Can J Public Health VL - 104 UR - https://doi.org/10.17269/cjph.104.3849 DO - 10.17269/cjph.104.3849 ID - Millar2013 ER - TY - JOUR AU - Hastings, G. PY - 2012 DA - 2012// TI - Why corporate power is a public health priority JO - BMJ. VL - 345 UR - https://doi.org/10.1136/bmj.e5124 DO - 10.1136/bmj.e5124 ID - Hastings2012 ER - TY - JOUR AU - Kickbusch, I. AU - Allen, L. AU - Franz, C. PY - 2016 DA - 2016// TI - The commercial determinants of health JO - Lancet Glob Health VL - 4 UR - https://doi.org/10.1016/S2214-109X(16)30217-0 DO - 10.1016/S2214-109X(16)30217-0 ID - Kickbusch2016 ER - TY - JOUR AU - Duvall, D. G. PY - 2006 DA - 2006// TI - Conflict of interest or ideological divide: the need for ongoing collaboration between physicians and industry JO - Curr Med Res Opin VL - 22 UR - https://doi.org/10.1185/030079906X120977 DO - 10.1185/030079906X120977 ID - Duvall2006 ER - TY - STD TI - Strom M. Coca-Cola’s Secret Plan to Monitor Sydney University Academic Lisa Bero. The Sydney Morning Herald. 2016. https://www.smh.com.au/technology/cocacolas-secret-plan-to-monitor-sydney-university-academic-lisa-bero-20161020-gs6m4a.html. Accessed 13 May 2019. UR - https://www.smh.com.au/technology/cocacolas-secret-plan-to-monitor-sydney-university-academic-lisa-bero-20161020-gs6m4a.html ID - ref11 ER - TY - STD TI - Wojcik J. Pharma Giant Threatens Danish Scientist. Science Nordic. 2012; http://sciencenordic.com/pharma-giant-threatens-danish-scientist. Accessed 13 May 2019. UR - http://sciencenordic.com/pharma-giant-threatens-danish-scientist ID - ref12 ER - TY - JOUR AU - Concannon, T. W. AU - Grant, S. AU - Welch, V. PY - 2019 DA - 2019// TI - Practical Guidance for Involving Stakeholders in Health Research JO - J Gen Intern Med VL - 34 UR - https://doi.org/10.1007/s11606-018-4738-6 DO - 10.1007/s11606-018-4738-6 ID - Concannon2019 ER - TY - JOUR AU - Fabbri, A. AU - Holland, T. J. AU - Bero, L. A. PY - 2018 DA - 2018// TI - Food industry sponsorship of academic research: investigating commercial bias in the research agenda JO - Public Health Nutr VL - 21 UR - https://doi.org/10.1017/S1368980018002100 DO - 10.1017/S1368980018002100 ID - Fabbri2018 ER - TY - JOUR AU - Fabbri, A. AU - Lai, A. AU - Grundy, Q. AU - Bero, L. A. PY - 2018 DA - 2018// TI - The influence of industry sponsorship on the research agenda: a scoping review JO - Am J Public Health VL - 108 UR - https://doi.org/10.2105/AJPH.2018.304677 DO - 10.2105/AJPH.2018.304677 ID - Fabbri2018 ER - TY - JOUR AU - Lathyris, D. N. AU - Patsopoulos, N. A. AU - Salanti, G. AU - Ioannidis, J. P. PY - 2010 DA - 2010// TI - Industry sponsorship and selection of comparators in randomized clinical trials JO - Eur J Clin Investig VL - 40 UR - https://doi.org/10.1111/j.1365-2362.2009.02240.x DO - 10.1111/j.1365-2362.2009.02240.x ID - Lathyris2010 ER - TY - JOUR AU - Vedula, S. S. AU - Li, T. AU - Dickersin, K. PY - 2013 DA - 2013// TI - Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin JO - PLoS Med VL - 10 UR - https://doi.org/10.1371/journal.pmed.1001378 DO - 10.1371/journal.pmed.1001378 ID - Vedula2013 ER - TY - STD TI - Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2017;(2):1465–858. ID - ref18 ER - TY - JOUR AU - Ebrahim, S. AU - Bance, S. AU - Athale, A. AU - Malachowski, C. AU - Ioannidis, J. P. PY - 2016 DA - 2016// TI - Meta-analyses with industry involvement are massively published and report no caveats for antidepressants JO - J Clin Epidemiol VL - 70 UR - https://doi.org/10.1016/j.jclinepi.2015.08.021 DO - 10.1016/j.jclinepi.2015.08.021 ID - Ebrahim2016 ER - TY - JOUR AU - Chartres, N. AU - Fabbri, A. AU - Bero, L. A. PY - 2016 DA - 2016// TI - Association of industry sponsorship with outcomes of nutrition studies: a systematic review and meta-analysis JO - JAMA Intern Med VL - 176 UR - https://doi.org/10.1001/jamainternmed.2016.6721 DO - 10.1001/jamainternmed.2016.6721 ID - Chartres2016 ER - TY - JOUR AU - Rose, S. L. AU - Highland, J. AU - Karafa, M. T. AU - Joffe, S. PY - 2017 DA - 2017// TI - Patient advocacy organizations, industry funding, and conflicts of interest JO - JAMA Intern Med VL - 177 UR - https://doi.org/10.1001/jamainternmed.2016.8443 DO - 10.1001/jamainternmed.2016.8443 ID - Rose2017 ER - TY - JOUR AU - Abola, M. V. AU - Prasad, V. PY - 2016 DA - 2016// TI - Industry funding of cancer patient advocacy organizations JO - Mayo Clin Proc VL - 91 UR - https://doi.org/10.1016/j.mayocp.2016.08.015 DO - 10.1016/j.mayocp.2016.08.015 ID - Abola2016 ER - TY - STD TI - Harris G. Drug Makers Are Advocacy Group’s Biggest Donors. 2009. https://www.nytimes.com/2009/10/22/health/22nami.html. Accessed 5 Sept 2018. UR - https://www.nytimes.com/2009/10/22/health/22nami.html ID - ref23 ER - TY - STD TI - Citizens Commission on Human Rights International. National Alliance on Mental Illness (NAMI) – A Pharma Front Group. 2009. https://www.cchrint.org/2009/10/22/nami-pharma-front-group/. Accessed 5 Sept 2018. UR - https://www.cchrint.org/2009/10/22/nami-pharma-front-group/ ID - ref24 ER - TY - JOUR AU - Rothman, S. M. AU - Raveis, V. H. AU - Friedman, A. AU - Rothman, D. J. PY - 2011 DA - 2011// TI - Health advocacy organizations and the pharmaceutical industry: an analysis of disclosure practices JO - Am J Public Health VL - 101 UR - https://doi.org/10.2105/AJPH.2010.300027 DO - 10.2105/AJPH.2010.300027 ID - Rothman2011 ER - TY - JOUR AU - Ong, E. K. AU - Glantz, S. A. PY - 2000 DA - 2000// TI - Tobacco industry efforts subverting International Agency for Research on Cancer's second-hand smoke study JO - Lancet VL - 355 UR - https://doi.org/10.1016/S0140-6736(00)02098-5 DO - 10.1016/S0140-6736(00)02098-5 ID - Ong2000 ER - TY - JOUR AU - Bes-Rastrollo, M. AU - Schulze, M. B. AU - Ruiz-Canela, M. AU - Martinez-Gonzalez, M. A. PY - 2013 DA - 2013// TI - Financial conflicts of interest and reporting bias regarding the association between sugar-sweetened beverages and weight gain: a systematic review of systematic reviews JO - PLoS Med VL - 10 UR - https://doi.org/10.1371/journal.pmed.1001578 DO - 10.1371/journal.pmed.1001578 ID - Bes-Rastrollo2013 ER - TY - JOUR AU - Wang, A. T. AU - McCoy, C. P. AU - Murad, M. H. AU - Montori, V. M. PY - 2010 DA - 2010// TI - Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review JO - BMJ. VL - 340 UR - https://doi.org/10.1136/bmj.c1344 DO - 10.1136/bmj.c1344 ID - Wang2010 ER - TY - JOUR AU - Persaud, N. PY - 2014 DA - 2014// TI - Questionable content of an industry-supported medical school lecture series: a case study JO - J Med Ethics VL - 40 UR - https://doi.org/10.1136/medethics-2013-101343 DO - 10.1136/medethics-2013-101343 ID - Persaud2014 ER - TY - BOOK AU - Nestle, M. PY - 2015 DA - 2015// TI - Soda Politics: Taking on Big Soda (and Winning) PB - Oxford University Press CY - New York ID - Nestle2015 ER - TY - JOUR AU - Sacks, G. AU - Swinburn, B. A. AU - Cameron, A. J. AU - Ruskin, G. PY - 2018 DA - 2018// TI - How food companies influence evidence and opinion–straight from the horse’s mouth JO - Crit Public Health VL - 28 UR - https://doi.org/10.1080/09581596.2017.1371844 DO - 10.1080/09581596.2017.1371844 ID - Sacks2018 ER - TY - STD TI - Rey-López JP, Gonzalez CA. Research partnerships between Coca-Cola and health organizations in Spain. Eur J Pub Health. 2018. https://doi.org/10.1093/eurpub/cky175. ID - ref32 ER - TY - JOUR AU - Rothman, D. J. AU - McDonald, W. J. AU - Berkowitz, C. D. PY - 2009 DA - 2009// TI - Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest JO - JAMA. VL - 301 UR - https://doi.org/10.1001/jama.2009.407 DO - 10.1001/jama.2009.407 ID - Rothman2009 ER - TY - BOOK AU - Chen, C. PY - 2018 DA - 2018// TI - FDA Repays Industry by Rushing Risky Drugs to Market ID - Chen2018 ER - TY - JOUR AU - Piller, C. PY - 2018 DA - 2018// TI - Hidden conflicts? JO - Science. VL - 361 UR - https://doi.org/10.1126/science.361.6397.16 DO - 10.1126/science.361.6397.16 ID - Piller2018 ER - TY - JOUR AU - Bien, J. AU - Prasad, V. PY - 2016 DA - 2016// TI - Future jobs of FDA’s haematology-oncology reviewers JO - BMJ. VL - 354 UR - https://doi.org/10.1136/bmj.i5055 DO - 10.1136/bmj.i5055 ID - Bien2016 ER - TY - JOUR AU - Fadlallah, R. AU - Alkhaled, L. AU - Brax, H. PY - 2017 DA - 2017// TI - Extent of physician–pharmaceutical industry interactions in low-and middle-income countries: a systematic review JO - Eur J Public Health VL - 28 UR - https://doi.org/10.1093/eurpub/ckx204 DO - 10.1093/eurpub/ckx204 ID - Fadlallah2017 ER - TY - JOUR AU - Grundy, Q. AU - Bero, L. AU - Malone, R. PY - 2013 DA - 2013// TI - Interactions between non-physician clinicians and industry: a systematic review JO - PLoS Med VL - 10 UR - https://doi.org/10.1371/journal.pmed.1001561 DO - 10.1371/journal.pmed.1001561 ID - Grundy2013 ER - TY - JOUR AU - Fischer, M. A. AU - Keough, M. E. AU - Baril, J. L. PY - 2009 DA - 2009// TI - Prescribers and pharmaceutical representatives: why are we still meeting? JO - J Gen Intern Med VL - 24 UR - https://doi.org/10.1007/s11606-009-0989-6 DO - 10.1007/s11606-009-0989-6 ID - Fischer2009 ER - TY - STD TI - Sci-com. Ethics and Principles for Science and Society Policy-making 20 Point Global Plan: The Brussels Declaration. 2017. http://www.euroscientist.com/wp-content/uploads/2017/02/Brussels-Declaration.pdf. Accessed 21 May 2019. UR - http://www.euroscientist.com/wp-content/uploads/2017/02/Brussels-Declaration.pdf ID - ref40 ER - TY - JOUR AU - McCambridge, J. AU - Daube, M. AU - McKee, M. PY - 2019 DA - 2019// TI - Brussels Declaration: a vehicle for the advancement of tobacco and alcohol industry interests at the science/policy interface? JO - Tob Control VL - 28 UR - https://doi.org/10.1136/tobaccocontrol-2018-054264 DO - 10.1136/tobaccocontrol-2018-054264 ID - McCambridge2019 ER - TY - JOUR AU - Abraham, J. PY - 2002 DA - 2002// TI - The pharmaceutical industry as a political player JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)11477-2 DO - 10.1016/S0140-6736(02)11477-2 ID - Abraham2002 ER - TY - JOUR AU - Wigand, J. S. PY - 1998 DA - 1998// TI - Cigarette testing methods, product design, and labelling: time to clean up the “negative baggage” JO - Tob Control VL - 7 UR - https://doi.org/10.1136/tc.7.4.336 DO - 10.1136/tc.7.4.336 ID - Wigand1998 ER - TY - JOUR AU - White, A. P. AU - Vaccaro, A. R. AU - Zdeblick, T. PY - 2007 DA - 2007// TI - Counterpoint: physician-industry relationships can be ethically established, and conflicts of interest can be ethically managed JO - Spine. VL - 32 UR - https://doi.org/10.1097/BRS.0b013e318053d54f DO - 10.1097/BRS.0b013e318053d54f ID - White2007 ER - TY - JOUR AU - Freudenberg, N. AU - Galea, S. PY - 2008 DA - 2008// TI - The impact of corporate practices on health: implications for health policy JO - J Public Health Policy VL - 29 UR - https://doi.org/10.1057/palgrave.jphp.3200158 DO - 10.1057/palgrave.jphp.3200158 ID - Freudenberg2008 ER - TY - STD TI - The Patient Protection and Affordable Care Act. Public Law 111-148. Vol. 3590. 2010. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf. Accessed 26 May 2019. UR - http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf ID - ref46 ER - TY - JOUR AU - McCoy, M. S. PY - 2018 DA - 2018// TI - Industry support of patient advocacy organizations: the case for an extension of the Sunshine Act Provisions of the Affordable Care Act JO - Am J Public Health VL - 108 UR - https://doi.org/10.2105/AJPH.2018.304467 DO - 10.2105/AJPH.2018.304467 ID - McCoy2018 ER - TY - JOUR AU - Schofferman, J. A. AU - Eskay-Auerbach, M. L. AU - Sawyer, L. S. AU - Herring, S. A. AU - Arnold, P. M. AU - Muehlbauer, E. J. PY - 2013 DA - 2013// TI - Conflict of interest and professional medical associations: the North American Spine Society experience JO - Spine J VL - 13 UR - https://doi.org/10.1016/j.spinee.2012.08.019 DO - 10.1016/j.spinee.2012.08.019 ID - Schofferman2013 ER - TY - BOOK PY - 2018 DA - 2018// TI - Our Actions and Way Forward ID - ref49 ER - TY - BOOK PY - 2018 DA - 2018// TI - List of Health Professionals and Scientific Experts ID - ref50 ER - TY - JOUR AU - Serôdio, P. M. AU - McKee, M. AU - Stuckler, D. PY - 2018 DA - 2018// TI - Coca-Cola–a model of transparency in research partnerships? A network analysis of Coca-Cola’s research funding (2008–2016) JO - Public Health Nutr VL - 21 UR - https://doi.org/10.1017/S136898001700307X DO - 10.1017/S136898001700307X ID - Serôdio2018 ER - TY - JOUR AU - Saver, R. S. PY - 2014 DA - 2014// TI - Shadows amid sunshine: regulating financial conflicts in medical research JO - Chest. VL - 145 UR - https://doi.org/10.1378/chest.13-1719 DO - 10.1378/chest.13-1719 ID - Saver2014 ER - TY - JOUR AU - Madureira Lima, J. M. AU - Galea, S. PY - 2018 DA - 2018// TI - Corporate practices and health: a framework and mechanisms JO - Glob Health VL - 14 UR - https://doi.org/10.1186/s12992-018-0336-y DO - 10.1186/s12992-018-0336-y ID - Madureira Lima2018 ER - TY - JOUR AU - Hiilamo, H. AU - Kahl, U. AU - Lambe, M. PY - 2009 DA - 2009// TI - The Philip Morris Nordic journalist program: Strategies, implementation and outcomes JO - Health Policy VL - 89 UR - https://doi.org/10.1016/j.healthpol.2008.05.003 DO - 10.1016/j.healthpol.2008.05.003 ID - Hiilamo2009 ER - TY - JOUR AU - Muggli, M. E. AU - Hurt, R. D. PY - 2003 DA - 2003// TI - Tobacco industry strategies to undermine the 8th World Conference on Tobacco or Health JO - Tob Control VL - 12 UR - https://doi.org/10.1136/tc.12.2.195 DO - 10.1136/tc.12.2.195 ID - Muggli2003 ER - TY - JOUR AU - Tong, S. AU - Olsen, J. PY - 2005 DA - 2005// TI - The threat to scientific integrity in environmental and occupational medicine JO - Occup Environ Med VL - 62 UR - https://doi.org/10.1136/oem.2005.021410 DO - 10.1136/oem.2005.021410 ID - Tong2005 ER - TY - JOUR AU - Rose, S. L. PY - 2013 DA - 2013// TI - Patient advocacy organizations: institutional conflicts of interest, trust, and trustworthiness JO - J Law Med Ethics VL - 41 UR - https://doi.org/10.1111/jlme.12078 DO - 10.1111/jlme.12078 ID - Rose2013 ER -